10-29291919-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032517.6(LYZL1):c.52G>A(p.Glu18Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000283 in 1,590,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032517.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LYZL1 | NM_032517.6 | c.52G>A | p.Glu18Lys | missense_variant | 2/5 | ENST00000649382.2 | |
LYZL1 | XM_005252627.4 | c.190G>A | p.Glu64Lys | missense_variant | 2/5 | ||
LYZL1 | XM_017016791.2 | c.190G>A | p.Glu64Lys | missense_variant | 2/5 | ||
LYZL1 | XR_428650.2 | n.238G>A | non_coding_transcript_exon_variant | 2/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LYZL1 | ENST00000649382.2 | c.52G>A | p.Glu18Lys | missense_variant | 2/5 | NM_032517.6 | P1 | ||
LYZL1 | ENST00000375500.8 | c.190G>A | p.Glu64Lys | missense_variant | 2/5 | 1 | |||
LYZL1 | ENST00000494304.1 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000703 AC: 10AN: 142302Hom.: 0 Cov.: 23
GnomAD3 exomes AF: 0.0000925 AC: 22AN: 237942Hom.: 0 AF XY: 0.0000701 AC XY: 9AN XY: 128336
GnomAD4 exome AF: 0.0000242 AC: 35AN: 1448626Hom.: 0 Cov.: 34 AF XY: 0.0000250 AC XY: 18AN XY: 719372
GnomAD4 genome AF: 0.0000703 AC: 10AN: 142302Hom.: 0 Cov.: 23 AF XY: 0.0000720 AC XY: 5AN XY: 69464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2024 | The c.190G>A (p.E64K) alteration is located in exon 2 (coding exon 2) of the LYZL1 gene. This alteration results from a G to A substitution at nucleotide position 190, causing the glutamic acid (E) at amino acid position 64 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at